What is the appropriate management for oleander (Nerium oleander) poisoning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Oleander Poisoning

For life-threatening oleander poisoning, administer digoxin-specific antibody fragments (digoxin-Fab) immediately as the primary antidote, guided by clinical severity and ECG findings rather than serum digoxin levels. 1

Immediate Assessment and Stabilization

Upon presentation, rapidly assess for:

  • Cardiac manifestations: Bradydysrhythmias (AV blocks), ventricular tachycardia/fibrillation, or asystole
  • Gastrointestinal symptoms: Nausea, vomiting, abdominal pain, diarrhea
  • Neurological signs: Confusion, altered mental status
  • Hyperkalemia: Critical prognostic indicator
  • ECG changes: Downsloping ST-segment depression characteristic of cardiac glycoside toxicity 2

Primary Treatment Algorithm

1. Digoxin-Fab Administration (First-Line Antidote)

It is reasonable to administer digoxin-Fab for oleander poisoning (Class 2a recommendation, C-LD evidence) 1. The 2023 AHA guidelines specifically mention yellow oleander (Thevetia peruviana) with Class 2a evidence, and by extension this applies to common oleander (Nerium oleander) as both contain similar cardiac glycosides 1.

Dosing strategy:

  • Dose empirically based on clinical severity, not serum digoxin levels 2, 3
  • Serum digoxin assays cross-react with oleander glycosides but do not accurately reflect total toxin burden 2, 3
  • Typical starting dose: 10-20 vials IV for severe toxicity 4, 5
  • May require repeated boluses if symptoms persist 2
  • Response typically occurs within 30-45 minutes 1

Critical caveat: After Fab administration, total serum digoxin levels become unreliable for guiding further therapy; use ECG findings and potassium levels instead 6

2. Gastrointestinal Decontamination

  • Activated charcoal: Administer if presenting within 1-2 hours of ingestion 7
  • Gastroscopy with mechanical removal: Always consider this if symptoms persist despite Fab administration, as oleander leaf phytobezoars can cause continuous toxin release 2
    • This is a unique and critical consideration for oleander poisoning
    • Gastric lavage alone may be insufficient 2

3. Dysrhythmia Management

For bradydysrhythmias:

  • Atropine may be reasonable (Class 2b, C-LD) 1, though response is variable 1
  • Electrical pacing may be reasonable (Class 2b, C-LD) 1 as temporizing therapy while awaiting Fab effect
    • Pitfall: Pacing complications occur in 36% of cases; higher-than-normal current may be required 1

For ventricular dysrhythmias:

  • Lidocaine or phenytoin may be reasonable (Class 2b, C-LD) 1 until digoxin-Fab takes effect
  • Avoid catecholaminergic agents (epinephrine, dopamine) as they can precipitate refractory ventricular fibrillation 6

4. Supportive Care

  • Correct hyperkalemia: Do NOT use calcium in hyperkalemia from cardiac glycoside poisoning (risk of "stone heart")
  • Continuous cardiac monitoring: Minimum 24 hours, longer if large ingestion or renal impairment 6
  • Avoid hemodialysis/hemoperfusion: Not effective due to large volume of distribution (Class 3: No Benefit) 1

Special Considerations

Delayed Recurrence

Anticipate delayed toxicity recurrence (12+ hours post-ingestion) with:

  • Large ingestions (>10-20 seeds or multiple leaves) 6
  • Acute kidney injury (impairs toxin elimination) 6
  • Presence of phytobezoar 2

This requires extended monitoring beyond initial clinical improvement and may necessitate additional Fab doses 6.

Refractory Cases

If patient develops refractory ventricular fibrillation or cardiogenic shock despite maximal therapy:

  • Consider VA-ECMO early in the treatment course 1, 6
  • Implementation takes time; initiate process before complete cardiovascular collapse 1
  • One fatal case report demonstrates that even VA-ECMO may be insufficient with massive ingestions 6

Key Pitfalls to Avoid

  1. Waiting for confirmatory testing: Treat immediately based on clinical presentation; do not delay Fab administration 1
  2. Relying on serum digoxin levels for dosing: These are unreliable for oleander toxicity 2, 3
  3. Missing persistent phytobezoar: Always consider gastroscopy if symptoms persist 2
  4. Premature discharge: Extended monitoring required, especially with renal impairment 6
  5. Using vasopressors inappropriately: Catecholamines can trigger fatal arrhythmias 6

Consultation

Contact poison control center or medical toxicologist immediately for all suspected oleander poisonings 1. This is emphasized as a top priority in the 2023 AHA guidelines given the specialized nature of cardiac glycoside poisoning management 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.